EcoDrugPlus

Casein Kinase I

Ensembl ID : ENSATEG00000008632
Gene Symbol: LOC113152628
2 Cross references
199 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSATEG00000006155
Gene Symbol: CASP9
2 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSATEG00000009551
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSATEG00000007121
Gene Symbol: CTSC
3 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSATEG00000000210
Gene Symbol: CTSK
3 Cross references
223 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSATEG00000020264
Gene Symbol: LOC113170972
2 Cross references
198 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSATEG00000000217
Gene Symbol: CTSS2.1
3 Cross references
235 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSATEG00000019104
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSATEG00000021185
Gene Symbol: CHEK1
1 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSATEG00000015835
Gene Symbol: CHEK2
2 Cross references
206 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9b

Ensembl ID : ENSATEG00000000224
Gene Symbol: CCR9B
2 Cross references
194 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 2

Ensembl ID : ENSATEG00000010867
Gene Symbol: CXCR2
2 Cross references
275 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).